Abstract:
:The antiphospholipid syndrome (APS) has occupied haemostaseologists, rheumatologists and obstetricians since its initial description 35 years ago. Its name has been coined because of the antibodies against phospholipids which were the common property of affected patients. In particular, the pathogenesis of APS has been intensively studied after the early discovery that it was possible to induce the clinical manifestations in animals by transfer of antiphospholipid antibodies (aPL). In recent years, it has become clear that aPL are not only structurally heterogeneous but also have different pathogenic properties. This review will focus on the relevance of antigenic specificity of aPL in terms of pathogenesis, diagnosis, and perhaps treatment of APS. :Das Antiphospholipidsyndrom (APS) beschäftigt Hämostaseologen, Rheumatologen und Geburtshelfer seit seiner ersten Beschreibung vor 35 Jahren. Sein Name wurde durch die Antikörper gegen Phospholipide geprägt, die bei den betroffenen Patienten gefunden wurden. Insbesondere nachdem frühzeitig erkannt worden war, dass die klinischen Manifestationen bei Tieren durch Übertragung von Antiphospholipid Antikörpern (aPL) induziert werden können, wurde die Pathogenese des APS intensiv untersucht. In den letzten Jahren wurde deutlich, dass aPL nicht nur strukturell heterogen sind, sondern auch unterschiedliche pathogene Eigenschaften aufweisen. Diese Übersichtsarbeit konzentriert sich auf die Relevanz der Antigenspezifität von aPL in Bezug auf Pathogenese, Diagnose und möglicherweise Behandlung von APS.
journal_name
Hamostaseologiejournal_title
Hamostaseologieauthors
Lackner KJ,Müller-Calleja Ndoi
10.1055/s-0038-1675355subject
Has Abstractpub_date
2019-06-01 00:00:00pages
188-194issue
2eissn
0720-9355issn
2567-5761journal_volume
39pub_type
杂志文章,评审相关文献
Hamostaseologie文献大全abstract:UNLABELLED:The retrospective cohort study surveys the influence of age, co-morbidity and laboratory values on FVIII-activity (FVIII:C) in patients with haemophilia A with (mild n = 48, moderate n = 10, severe n = 7 and carriers n = 23). Median observation was 19 years for patients with haemophilia A and 9,5 years for c...
journal_title:Hamostaseologie
pub_type: 杂志文章
doi:
更新日期:2011-11-01 00:00:00
abstract::Superficial vein thrombosis (SVT) is a common disease, characterized by an inflammatory-thrombotic process in a superficial vein. Typical clinical findings are pain and a warm, tender, reddish cord along the vein. Until recently, no reliable epidemiological data were available. The incidence is estimated to be higher ...
journal_title:Hamostaseologie
pub_type: 杂志文章
doi:10.5482/HAMO-13-04-0027
更新日期:2013-08-01 00:00:00
abstract::Several challenges arise from the wide application of molecular genetic analyses, among them the need to introduce rules to evaluate molecular genetic test systems as well as test laboratories. This article specifically addresses laboratories performing molecular genetic tests for diagnosis, prevention and therapy of ...
journal_title:Hamostaseologie
pub_type: 杂志文章
doi:
更新日期:2010-05-01 00:00:00
abstract::Recurrent venous thromboembolism is associated with increased mortality in 5-9% of the patients. On the other hand prolonged anticoagulation can increase the bleeding risk which can also be responsible for an increased mortality. Therefore, it is necessary to validate the recurrence risk of venous thromboembolism on a...
journal_title:Hamostaseologie
pub_type: 杂志文章,评审
doi:10.5482/ha-1144
更新日期:2011-02-01 00:00:00
abstract::Myocardial infarction (MI) shows a strong heritability. For a long time the identification of responsible genes has been rather unsuccessful. However, with the advent of genome wide association studies (GWAS) using DNA-array technology a number of significant loci for MI have been identified which were widely replicat...
journal_title:Hamostaseologie
pub_type: 杂志文章
doi:
更新日期:2010-11-01 00:00:00
abstract::Cardiovascular and especially thrombotic diseases remain a major cause of morbidity and mortality worldwide. In past years, significant improvements in understanding disease processes, risk assessment, and prediction of clinical outcome in the field of thrombosis and haemostasis have been made by using large-scale bio...
journal_title:Hamostaseologie
pub_type: 杂志文章,评审
doi:10.1055/s-0038-1677520
更新日期:2019-06-01 00:00:00
abstract::Vitamin-K-antagonists (VKA) and heparins have been complementary anticoagulants for prevention and treatment of thrombosis for almost 70 years. In contrast to heparins, VKA have not been modified pharmacologically, however treatment surveillance has improved by introducing INR and self-monitoring/management. Disclosur...
journal_title:Hamostaseologie
pub_type: 杂志文章,评审
doi:10.5482/ha-1149
更新日期:2011-02-01 00:00:00
abstract::Acquired haemophilia A (AHA) is caused by autoantibody inhibitors of coagulation factor VIII (FVIII : C). Recent onset of bleeds and isolated prolongation of the activated partial thromboplastin time (aPTT) are characteristic features of the disorder. Reduced FVIII : C activity and a detectable FVIII : C inhibitor in ...
journal_title:Hamostaseologie
pub_type: 杂志文章,评审
doi:10.5482/HAMO-14-11-0064
更新日期:2015-01-01 00:00:00
abstract::Characteristic features of disseminated intravascular coagulation (DIC) are the opposing risks of bleeding (due to consumptive coagulopathy and hyperfibrinolysis) and organ failure (due to widespread microvascular thromboses). The purpose of anticoagulation in DIC is to attenuate excessive thrombin generation and fibr...
journal_title:Hamostaseologie
pub_type: 杂志文章
doi:10.1055/s-0038-1675386
更新日期:2019-08-01 00:00:00
abstract::Epidemiological studies revealed that most antineoplastic agents and regimes enhance the risk of venous and arterial thromboembolic events in cancer patients. The purpose of this article is to review clinical and pathophysiological data related to chemotherapy-associated thromboembolism under special consideration of ...
journal_title:Hamostaseologie
pub_type: 杂志文章,评审
doi:
更新日期:2009-01-01 00:00:00
abstract::By the use of conventional anticoagulants, significant improvements were achieved in all fields of medicine. Although efficacious and widely used, their use is limited in several respects. In particular, the use of vitamin K antagonists is restricted in the clinical routine setting. The main reasons are the delayed on...
journal_title:Hamostaseologie
pub_type: 杂志文章,评审
doi:
更新日期:2002-08-01 00:00:00
abstract::Unexplained intraoperative coagulopathies continue to be a diagnostic and therapeutic dilemma. The pathophysiology behind unexplained intraoperative coagulopathies is of great variety and complexity (preexisting coagulopathies, dilutional coagulopathy, interactions of medications etc.). We have shown in prospective st...
journal_title:Hamostaseologie
pub_type: 杂志文章
doi:
更新日期:2006-08-01 00:00:00
abstract::Placenta-mediated pregnancy complications are clinically important conditions and include preeclampsia, placental abruption, intrauterine growth restriction, and late fetal loss. Pathophysiology is complex, and may be linked to prothrombotic disorders such as antiphospholipid syndrome, whose understanding is still evo...
journal_title:Hamostaseologie
pub_type: 杂志文章
doi:10.1055/a-1184-8388
更新日期:2020-08-01 00:00:00
abstract::Current antithrombotic therapy in patients with acute coronary syndrome (ACS) comprises antiplatelet and anticoagulant therapy. Dual antiplatelet therapy composed of aspirin plus a third generation P2Y12 inhibitor (prasugrel or ticagrelor) represents the gold standard, while aspirin plus second generation P2Y12 inhibi...
journal_title:Hamostaseologie
pub_type: 杂志文章,评审
doi:10.5482/HAMO-13-09-0048
更新日期:2014-01-01 00:00:00
abstract::The antiphospholipid syndrome is defined as the occurrence of one or more episodes of vascular thrombosis and/or miscarriage together with antiphospholipid antibodies. Some of these antibodies can be detected via coagulation assays by prolonging phospholipids-dependent assays. These unspecific inhibitors are termed lu...
journal_title:Hamostaseologie
pub_type: 杂志文章,评审
doi:10.1267/hämo05010050
更新日期:2005-02-01 00:00:00
abstract::In Germany one-third of the women in fertile age use combined oral contraceptives (COCs), which consist mostly of ethinylestradiol (EE) and a synthetic progestin. Older COCs with norethisterone or levonorgestrel have a lower risk for venous thromboembolism (VTE) than newer COCs with desogestrel, drospirenone, or gesto...
journal_title:Hamostaseologie
pub_type: 杂志文章,评审
doi:10.1055/s-0039-1677806
更新日期:2019-02-01 00:00:00
abstract::Von Willebrand factor (VWF) structure-function relationship has been studied only through in vitro approaches. The VWF-deficient mouse model has been extremely useful to examine the in vivo function of VWF but does not allow a more subtle analysis of the relative importance of its different domains. However, consideri...
journal_title:Hamostaseologie
pub_type: 杂志文章
doi:
更新日期:2009-01-01 00:00:00
abstract:UNLABELLED:An adequate number of qualified haemophilia centres is an essential requirement for effective and cost-efficient haemophilia care. During a reassessment of the delivery of haemophilia care in Germany a broad range of criteria relating to structure and quality of the centres were defined and a questionnaire w...
journal_title:Hamostaseologie
pub_type: 杂志文章
doi:
更新日期:2012-01-01 00:00:00
abstract::We describe the case of a 30-year-old woman with homozygous prothrombin G20210A transition and heterozygous FV Leiden mutation and a history of postpartum venous thrombosis. Despite the high thrombotic risk to be assumed in the presence of this combined thrombophilia our patient suffered her first venous thrombotic ev...
journal_title:Hamostaseologie
pub_type: 杂志文章
doi:
更新日期:2003-08-01 00:00:00
abstract::Cardiovascular disease is the major cause of morbidity and mortality in subjects suffering from diabetes mellitus. While coronary artery disease is the leading cause of cardiac complications in diabetics, it is widely recognized that diabetes increases the risk for the development of heart failure independently of cor...
journal_title:Hamostaseologie
pub_type: 杂志文章,评审
doi:10.5482/HAMO-14-09-0038
更新日期:2015-01-01 00:00:00
abstract::The antiphospholipid syndrome (APS) is defined by the association of arterial and/or venous thrombosis and/or pregnancy complications with the presence of at least one among the main antiphospholipid antibodies (aPL) (i. e., Lupus anticoagulants, LA, IgG and/or IgM anticardiolipin antibodies, aCL, IgG and/or IgM antiβ...
journal_title:Hamostaseologie
pub_type: 杂志文章,评审
doi:10.5482/ha-1165
更新日期:2011-11-01 00:00:00
abstract::Recent advances in the diagnosis and the treatment of acute coronary syndromes (ACS) have led to a substantial reduction of major coronary events, to an improvement in patient outcome and the definition of new guidelines. Current strategies for the treatment of patients with non-ST-elevation ACS recommend a combined a...
journal_title:Hamostaseologie
pub_type: 杂志文章
doi:
更新日期:2007-12-01 00:00:00
abstract::Acquired haemophilia A (AHA) is a rare autoimmune disease caused by antibodies directed against clotting factor VIII. About half of cases are idiopathic, but AHA may also be secondary to autoimmune, dermatologic, or oncologic diseases. In approximately 10% of non-idiopathic cases, the disease occurs after or with the ...
journal_title:Hamostaseologie
pub_type: 杂志文章
doi:10.1055/s-0038-1668570
更新日期:2019-02-01 00:00:00
abstract::Replacement therapy of coagulation factor preparations (AT, FFP, PPSB, FXIII, rFVIIa) are frequently used on the Intensive Care Units. Indications, dosage, specific effects and side effects have to be considered. ...
journal_title:Hamostaseologie
pub_type: 杂志文章,评审
doi:10.1267/hämo05020209
更新日期:2005-05-01 00:00:00
abstract:UNLABELLED:The retrospective observational study surveys the relationship between development of inhibitors in the treatment of haemophilia patients and risk factors such as changing FVIII products. A total of 119 patients were included in this study, 198 changes of FVIII products were evaluated. RESULTS:During the ob...
journal_title:Hamostaseologie
pub_type: 杂志文章
doi:
更新日期:2012-01-01 00:00:00
abstract::This is a very short review on quantitative coagulation factor assays for the beginner. For systematic training several excellent textbooks in German language are available. Quantitative functional assays of coagulation factors and of physiological inhibitor proteins are based on the principle of parallel-line or slop...
journal_title:Hamostaseologie
pub_type: 杂志文章,评审
doi:
更新日期:2006-01-01 00:00:00
abstract:UNLABELLED:Clinical expression of inadequately treated haemophilia is dominated by orthopedic complications, requiring invasive or non-invasive interventions. OBJECTIVE:In Romania, with under dosed and late introduced "on demand" substitution, we aimed at highlighting the experience of orthopedic treatment and its out...
journal_title:Hamostaseologie
pub_type: 杂志文章
doi:
更新日期:2008-10-01 00:00:00
abstract::Von Willebrand disease (VWD) is known for its marked heterogeneity which was already recognized by von Willebrand in 1926. The basis of phenotypic differentiation are quantitative and qualitative or functional differences between the different types and subtypes of VWD. One of the most important tools in the classific...
journal_title:Hamostaseologie
pub_type: 杂志文章,评审
doi:10.1267/hamo04010027
更新日期:2004-02-01 00:00:00
abstract::Obesity is a major cause for a spectrum of metabolic syndrome-related diseases that include insulin resistance, type 2 diabetes, and steatosis of the liver. Inflammation elicited by macrophages and other immune cells contributes to the metabolic abnormalities in obesity. In addition, coagulation activation following t...
journal_title:Hamostaseologie
pub_type: 杂志文章,评审
doi:10.5482/HAMO-14-11-0068
更新日期:2015-01-01 00:00:00
abstract::Thrombocytosis (defined as platelets >450 x 109/l) has several aetiologies. After having excluded spurious thrombocytosis (e. g., due to microspherocytes, schistocytes, cryoglobulins, or bacteria), the differential diagnosis of true thrombocytosis encompasses secondary causes (as diverse as inflammation, infection, ma...
journal_title:Hamostaseologie
pub_type: 杂志文章,评审
doi:10.5482/HAMO-14-11-0074
更新日期:2016-11-07 00:00:00